SIRION Biotech Licenses Adenovirus Technology to Danish Startup, InProTher for its Novel Immunotherapy Design Targeting Endogenous Retrovirus (ERV)
MUNICH & COPENHAGEN, Denmark--(BUSINESS WIRE)--Feb 4, 2020-- |!| Ludington
MUNICH & COPENHAGEN, Denmark--(BUSINESS WIRE)--Feb 4, 2020-- |!| Ludington